Search

Your search keyword '"Frankova, Sona"' showing total 164 results

Search Constraints

Start Over You searched for: Author "Frankova, Sona" Remove constraint Author: "Frankova, Sona"
164 results on '"Frankova, Sona"'

Search Results

1. Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ)

2. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

3. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

4. Alcohol consumption and liver phenotype of individuals with alpha‐1 antitrypsin deficiency.

5. Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease

6. PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease

8. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

10. Alpha-1 antitrypsin (AAT) augmentation and the liver phenotype of adults with AAT deficiency (genotype Pi*ZZ)

11. PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune liver disease

12. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study

13. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

15. Impact of alcohol consumption on the liver phenotype in alpha-1 antitrypsin deficiency

18. Low Frequency of Cancer-Predisposition Gene Mutations in Liver Transplant Candidates with Hepatocellular Carcinoma

21. Predictors of Significant Liver Fibrosis in People with Chronic Hepatitis C Who Inject Drugs in the Czech Republic.

22. WED-135-YI Impact of metabolic alterations on liver phenotype of patients with homozygous alpha-1 antitrypsin deficiency (Pi*ZZ)

23. TOP-141 Longitudinal assessment of individuals with homozygous alpha-1 antitrypsin deficiency (Pi*ZZ genotype) provides evidence for clinical patient management

25. HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons

26. Low Frequency of Cancer-Predisposition Gene Mutations in Liver Transplant Candidates with Hepatocellular Carcinoma.

27. Alpha-1 Antitrypsin and Hepatocellular Carcinoma in Liver Cirrhosis: SERPINA1 MZ or MS Genotype Carriage Decreases the Risk

30. Is elimination of HCV in 2030 realistic in Central Europe

31. Liver stiffness measured by two-dimensional shear-wave elastography predicts hepatic vein pressure gradient at high values in liver transplant candidates with advanced liver cirrhosis

34. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

35. How close are we to hepatitis C virus elimination in Central Europe?

39. Aquaporin-2 excretion in hospitalized patients with cirrhosis: Relation to development of renal insufficiency and mortality

41. Aquaporin-2 excretion in hospitalized patients with cirrhosis:Relation to development of renal insufficiency and mortality

42. Combination of sofosbuvir and daclatasvir in the treatment of genotype 3 chronic hepatitis C virus infection in patients on maintenance hemodialysis

48. USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study

Catalog

Books, media, physical & digital resources